Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | PARP1 | P09874 | 1/20 | 0.40 |
| ▸ | TYMS | P04818 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.38 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.38 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | CDC25B | P30305 | 2/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | WDR5 | P61964 | 1/20 | 0.36 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL346772 | 0.91 | HSD17B10 (0.44) | CYP1A2PARP1TYMSHSD17B10HPGD | |
| SCHEMBL10350465 | 0.89 | TYMS (0.44) | CYP1A2PARP1TYMSHSD17B10HPGD | |
| SCHEMBL15844184 | 0.89 | TYMS (0.44) | CYP1A2PARP1TYMSHSD17B10HPGD | |
| SCHEMBL29054769 | 0.88 | HSD17B10 (0.44) | CYP1A2HSD17B10HPGDMEN1CYP2C19 | |
| SCHEMBL9353923 | 0.84 | HPGD (0.37) | CYP1A2PARP1TYMSHSD17B10HPGD | |
| SCHEMBL28774731 | 0.83 | PTPN1 (0.44) | CYP1A2TYMSHSD17B10HPGDMEN1 | |
| SCHEMBL2173708 | 0.82 | CYP1A2 (0.58) | CYP1A2PARP1TYMSHSD17B10HPGD | |
| SCHEMBL6570619 | 0.80 | KMT2A (0.46) | CYP1A2HSD17B10HPGDMEN1CYP2C19 | |
| SCHEMBL4412297 | 0.80 | CYP1A2 (0.42) | CYP1A2PARP1HSD17B10HPGDMEN1 | |
| SCHEMBL9135098 | 0.80 | MEN1 (0.42) | CYP1A2HSD17B10HPGDMEN1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070009751-A1 | Polyamic acid resin composition modified with laminate nanometer silica sheet and polyimide prepared therefrom | CHANG CHUN PLASTICS CO., LTD. (TW) | 2007-01-11 | — | — | US | claimed |
| CN-1269905-C | Organic and inorganic mixed thin-membrane materials and preparing method thereof | CHANGCHUN ARTIFICIAL RESIN FAC (CN) | 2006-08-16 | — | — | CN | claimed |
| US-7005163-B2 | Organic-inorganic hybrid film material and its fabrication | CHANG CHUN PLASTICS CO., LTD. (TW) | 2006-02-28 | — | — | US | claimed |
| CN-1583881-A | Organic and inorganic mixed thin-membrane materials and preparing method thereof | CHANGCHUN ARTIFICIAL RESIN FAC (CN) | 2005-02-23 | — | — | CN | claimed |
| US-20040110014-A1 | Organic-inorganic hybrid film material and its fabrication | CHANG CHUN PLASTICS CO., LTD. (TW) | 2004-06-10 | — | — | US | claimed |
| EP-0362649-B1 | Radiation-sensitive compositions and their use | BASF AG (DE) | 1994-03-02 | — | — | EP | claimed |
| US-5284734-A | Insulating layers and printed circuits; precursors for polyimides and polyquinazolines | BASF AKTIENGESELLSCHAFT (DE) | 1994-02-08 | — | — | US | claimed |
| EP-0362649-A2 | Radiation-sensitive compositions and their use | BASF Aktiengesellschaft (DE) | 1990-04-11 | — | — | EP | claimed |
| EP-3325533-B1 | CURABLE BENZOXAZINE COMPOSITIONS | HUNTSMAN ADVANCED MAT AMERICAS LLC (US) | 2023-09-13 | — | — | EP | disclosed |
| US-11319410-B2 | Precursor for polyimide and use thereof | ETERNAL MATERIALS CO., LTD. (TW) | 2022-05-03 | — | — | US | disclosed |
| CN-107995916-B | Curable benzoxazine compositions | 亨斯迈先进材料美国有限责任公司 | 2021-08-10 | — | — | CN | disclosed |
| CN-107189067-B | Polyimide precursor and application thereof | 长兴材料工业股份有限公司 | 2021-01-05 | — | — | CN | disclosed |
| US-10851049-B2 | Curable benzoxazine compositions | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) | 2020-12-01 | — | — | US | disclosed |
| US-10765008-B2 | Metal clad laminate, preparation method thereof, and method for preparing flexible circuit board by using the same | ETERNAL MATERIALS CO., LTD. (TW) | 2020-09-01 | — | — | US | disclosed |
| US-4677186-A | AMINO DICARBOXYLIC ACID MONOMERS, PROTECITVE COATINGS | CIBA-GEIGY CORPORATION (US) | 1987-06-30 | — | — | US | disclosed |
| US-4657832-A | HOMO-AND COPOLYMERS, OF POLYIMIDES, POLYAMIDES, POLYESTERS AND OTHERS | CIBA-GEIGY CORPORATION (US) | 1987-04-14 | — | — | US | disclosed |
| US-4656116-A | CROSSLINKABLE SOLUTIONS OF SOLVENT, POLYIMIDE AND POLYAZIDE CHROMOGEN; PHOTORESISTS; PHOTOLITHOGRAPHY | CIBA-GEIGY CORPORATION (US) | 1987-04-07 | — | — | US | disclosed |
| US-4629777-A | RADIATION-SENSITIVE, AUTOPHOTOCROSSLINKABLE; FILMS, COATINGS | CIBA-GEIGY CORPORATION (US) | 1986-12-16 | — | — | US | disclosed |
| US-4629685-A | PROTECTIVE FILMS OR PHOTOGRAPHIC RELIEF IMAGES | CIBA-GEIGY CORPORATION (US) | 1986-12-16 | — | — | US | disclosed |
| US-4548891-A | PHOTORESISTS; HEAT RESISTANCE; THICKNESS; SHARPNESS | CIBA GEIGY CORPORATION (US) | 1985-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10851049-B2 | Curable benzoxazine compositions | CBX4, CRYZ, CBX8 | CYP1A2 1556/4885PARP1 247/4885TYMS 3171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.